Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

ValiRx (VAL) Regulatory News

Date Source Headline
20th Sep 2017 3:18 pm RNS VAL201 update
19th Sep 2017 7:00 am RNS Issue of Equity
13th Sep 2017 9:34 am RNS Hardman Research: GeneICE and VAL101 progress
7th Sep 2017 7:00 am RNS GeneICE & VAL101 Update
11th Aug 2017 7:00 am RNS Convertible Loan Facility
2nd Aug 2017 7:00 am RNS Conversion of Loan Note
28th Jul 2017 7:00 am RNS Licencing Agreement
22nd Jun 2017 7:00 am RNS Formation of & Appointments to an Advisory Board
15th Jun 2017 7:00 am RNS ValiSeek Development Update - Recruitment Closes
1st Jun 2017 11:00 am RNS Yorkville CLN Conversion
31st May 2017 11:00 am RNS Hardman Research:Developing novel cancer therapies
30th May 2017 10:34 am RNS Result of AGM
24th May 2017 7:00 am RNS NOTIFICATION OF AUSTRALIAN PATENT ALLOWANCE
5th May 2017 5:28 pm RNS Notice of AGM
5th May 2017 7:00 am RNS Final Results
27th Apr 2017 10:07 am RNS Re: SHARES Magazine Supplement on ValiRx website
19th Apr 2017 9:00 am RNS Change of Registered Office
15th Mar 2017 9:33 am RNS Director/PDMR Shareholding
8th Mar 2017 7:00 am RNS ValiSeek Clinical Development Update
2nd Mar 2017 7:00 am RNS Director/PDMR Shareholding
1st Mar 2017 1:37 pm RNS Placing to raise £1.16m and Proposed Subscription
28th Feb 2017 7:00 am RNS Publication of Peer-Reviewed Articles on VAL401
11th Jan 2017 7:00 am RNS CLINICAL TRIAL UPDATE - Positive VAL201 Results
30th Dec 2016 7:00 am RNS Yorkville CLN Conversion
8th Dec 2016 7:00 am RNS European Patent Granted for Lead Compound VAL201
2nd Dec 2016 4:15 pm RNS Convertible Loan Facility
1st Dec 2016 7:00 am RNS ValiSeek Clinical Development Update
29th Nov 2016 7:00 am RNS Quarterly Update on Clinical Developments
3rd Nov 2016 7:00 am RNS ValiSeek Clinical Development Update
28th Oct 2016 9:00 am RNS Corporate Video re Clinical Status Q4, 2016
25th Oct 2016 7:00 am RNS Patent Update
13th Oct 2016 4:20 pm RNS Holding(s) in Company
13th Oct 2016 4:20 pm RNS Holding(s) in Company
13th Oct 2016 7:00 am RNS Update on Recent Presentations
12th Oct 2016 11:15 am RNS Result of General Meeting
5th Oct 2016 3:42 pm RNS CLN Conversion
28th Sep 2016 11:09 am RNS Notice of GM
27th Sep 2016 7:00 am RNS Half-year Report
26th Sep 2016 7:00 am RNS ValiRx selected for The Parliamentary Review 2016
13th Sep 2016 7:00 am RNS Quarterly Update on Clinical Developments
FTSE 100 Latest
Value8,843.20
Change33.46